Amid ongoing uncertainties surrounding international tariffs, Swiss pharmaceutical giant Novartis has announced a significant investment in the United States, unveiling plans to build a $1.1 billion research and development hub in San Diego. This major commitment underscores the company’s confidence in the region’s biotech ecosystem and signals a strategic move to bolster innovation and drug discovery efforts despite global trade tensions. The new facility is expected to create hundreds of jobs and position San Diego as a key center for cutting-edge pharmaceutical research.
Swiss Pharmaceutical Giant Advances Amid Global Tariff Challenges
Despite the increasing pressure from global tariffs and trade restrictions, the Swiss pharmaceutical leader has announced a bold investment…
—-
Author : Miles Cooper
Publish date : 2025-12-28 06:43:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8
